Stock Med

What Stock Med does

Stock Med is a Brazilian B2B distributor of pharmaceuticals and medical-hospital supplies, headquartered in Santa Cruz do Sul, Rio Grande do Sul. Founded on February 3, 2014 by pharmacist Fernando Henrique Mossmann alongside partner-director Milton Júnior Mainardi, the company serves healthcare institutions nationwide — including hospitals, medical and dental clinics, oncological clinics, clinical analysis laboratories, pharmacies, veterinary clinics, and home care providers — with products sold exclusively to legal entities (CNPJ holders). The portfolio is organized into six therapeutic and clinical catalogs: Medicamentos, Nutrição, Oncologia, Materiais Hospitalares, Diagnóstica, and Estética, distributed from a single 3,000 sqm centralized hub opened in August 2016.

The company's core technology is the 'Listro' Warehouse Management System, co-developed with Qualify Informática and implemented in November 2020, specifically designed for healthcare distribution. Listro automates receiving, storage, and shipping processes and is integrated with 2D data collectors, Data Matrix-coded product labels, and an Android-based operational stack to enable full traceability from entry to delivery. The technology is positioned as a differentiator for logistics reliability rather than as a product sold externally. Stock Med also operates as a channel partner for multiple major pharmaceutical and nutrition brands, including Geolab, Prati, Biolab, Cristália, Fresenius Kabi, Blau, Supermax, and Prodiet.

Stock Med's revenue model is transaction-based on product distribution, augmented by technical advisory services delivered by a multidisciplinary team spanning pharmacy, nursing, nutrition, psychology, and administration. The go-to-market is sales-led and quote-driven: institutional buyers initiate purchases through the website, toll-free 0800 number, email, or WhatsApp, with no direct consumer channel. Geographic reach covers 800+ municipalities across 25 of 27 Brazilian states. Revenue tripled in 2020 to R$ 77 million, with a publicly stated 2021 target of R$ 150 million; no post-2021 financial disclosures are available. Marketing is conducted via social media (Instagram, Facebook, LinkedIn), the Stock News newsletter, downloadable product catalogs, and community sponsorships, including a flagship master-sponsorship of the Stock Med/União Corinthians basketball team.

Name

Stock Med

Legal name

Stock Med

Website

https://stockmed.com.br

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

Stock Med is a Brazilian B2B distributor of pharmaceuticals and medical-hospital supplies headquartered in Santa Cruz do Sul, Rio Grande do Sul, serving hospitals, clinics, pharmacies, laboratories, and home care providers across 25 states with proprietary logistics technology.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Pharmaceutical and Medicine Manufacturing (3254)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Pharmaceutical distribution
• Medical supplies wholesale
• Hospital materials supply
• Oncology products distribution
• Healthcare logistics services

Headquarters

HQ city

Santa Cruz Do Sul

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Distribution of medications and medical-hospital supplies to healthcare institutions, pharmacies, clinics, and hospitals across Brazil. Revenue generated through product sales with technical advisory services as a key differentiator.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Stock Med is a B2B pharmaceutical and medical-hospital supplies distributor that sells medications, hospital materials, nutrition, oncology, diagnostic, and aesthetics products to healthcare institutions across Brazil. The company operates a 3,000 m² distribution center supported by a WMS, technical pharmaceutical advisory, and a multidisciplinary commercial team, with sales executed exclusively to legal entities (CNPJ) through catalogs and quote-based ordering.

Product overview

Stock Med is a pharmaceutical and medical-hospital supplies distributor operating in Brazil. The company offers a portfolio of product catalogs organized by therapeutic category: Medicamentos (medications), Nutrição (nutrition supplements), Oncologia (oncology products), Materiais Hospitalares (hospital materials), Diagnóstica (diagnostic products), and Estética (aesthetic supplies). The product line is complemented by Stock News, a periodic informational newsletter. Stock Med functions as a B2B distributor serving healthcare institutions across multiple segments including hospitals, clinics, pharmacies, laboratories, and home care providers. The company emphasizes technical advisory services alongside product distribution.

Differentiator

Problem solved

Functional benefit

Products and services

• Medicamentos (Medications Catalog) Distribution catalog of medications for B2B healthcare buyers (hospitals, clinics, pharmacies, laboratories) in Brazil, sold exclusively to CNPJ-registered legal entities via quote-based ordering supported by technical pharmaceutical advisory.
• Nutrição (Nutrition Catalog) Catalog of clinical and enteral nutrition products distributed to B2B healthcare institutions in Brazil for use in hospital and clinic patient care.
• Oncologia (Oncology Catalog) Specialty catalog of oncology products distributed to B2B hospitals, clinics, and oncology centers in Brazil, with pharmacist-led advisory for safe handling and administration.
• Materiais Hospitalares (Hospital Materials Catalog) Catalog of medical-hospital supplies (consumables and equipment-related inputs) distributed to B2B hospitals, clinics, and laboratories across Brazil.
• Diagnóstica (Diagnostics Catalog) Catalog of diagnostic products distributed to B2B clinical laboratories and diagnostic centers in Brazil.
• Estética (Aesthetics Catalog) Catalog of aesthetics products distributed to B2B licensed aesthetic clinics and healthcare institutions in Brazil.
• Stock News Informativo (Industry Newsletter) Periodic informational newsletter publication that shares healthcare-sector news and updates from Stock Med to customers and prospects; published as a brand content asset rather than a paid product.

Quantifiable outcome

• Tripled revenue in 2020, reaching R$ 77 million - highest in company history
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core, minor and flagship.

• Qualify InformáticacoreTechnology or Integration · 1 November 2020Technology partnership for WMS (Warehouse Management System) implementation. Qualify Informática developed the 'Listro' WMS specifically for Stock Med's healthcare distribution operations. The system was implemented starting November 2020 with physical environment structuring and staff training.
• GeolabminorChannel Partner/ Reseller/ DistributorBrand partnership - distributes Geolab pharmaceutical products through Stock Med's distribution network.
• PratiminorChannel Partner/ Reseller/ DistributorBrand partnership - distributes Prati pharmaceutical products through Stock Med's distribution network.
• BiolabminorChannel Partner/ Reseller/ DistributorBrand partnership - distributes Biolab pharmaceutical products through Stock Med's distribution network.
• CristaliaminorChannel Partner/ Reseller/ DistributorBrand partnership - distributes Cristalia pharmaceutical products through Stock Med's distribution network.
• Fresenius KabiminorChannel Partner/ Reseller/ DistributorBrand partnership - distributes Fresenius Kabi pharmaceutical products through Stock Med's distribution network.
• ProdietminorChannel Partner/ Reseller/ DistributorBrand partnership - distributes Prodiet nutrition products through Stock Med's distribution network.
• Esporte Clube União CorinthiansflagshipStrategic or Co-development PartnerMaster sponsor of the Stock Med/União Corinthians basketball team. The team won the Brazilian Basketball Championship in 2021, representing Santa Cruz do Sul at national competitions. This is the company's flagship sponsorship partnership for community engagement and brand visibility.
• SupermaxminorChannel Partner/ Reseller/ DistributorBrand partnership - distributes Supermax medical supply products through Stock Med's distribution network.
• BlauminorChannel Partner/ Reseller/ DistributorBrand partnership - distributes Blau pharmaceutical products through Stock Med's distribution network.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Eurofarma: Major Brazilian pharmaceutical manufacturer with its own distribution arm and institutional sales force. Comparable as a vertically integrated supplier/distributor that Stock Med both partners with and competes against for institutional contracts.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical distribution giant operating in Brazil through Alliance Healthcare. Comparable as a benchmark for scale, manufacturer negotiating leverage, and institutional distribution capabilities that Stock Med aspires to build.
• McKesson: Global pharmaceutical and medical supplies distributor. Comparable as a benchmark for distribution operating models, traceability technology, and institutional healthcare supply contracts relevant to Stock Med's ambitions.
• Biolab: Brazilian pharmaceutical manufacturer and one of Stock Med's key brand partners. Comparable as a vertically positioned player whose products Stock Med distributes and whose direct-to-institution strategy affects Stock Med's catalog economics.
• Hypera Pharma: Largest Brazilian pharmaceutical company by revenue, with a portfolio of branded, generic, and consumer health products distributed nationally. Comparable in the breadth of healthcare categories and institutional reach.
• Cristália: Brazilian pharmaceutical manufacturer and Stock Med distribution partner with institutional sales capability. Comparable as a supplier that competes with Stock Med for direct hospital and clinic relationships in specialty segments.
• Cimed: Large Brazilian pharmaceutical company with national distribution capabilities. Comparable in product breadth and reach into the institutional and retail channels Stock Med serves.

Emerging players

• Blau Farmacêutica: Brazilian pharmaceutical manufacturer focused on specialty and hospital products and a Stock Med distribution partner. Comparable in the specialty and institutional segment where both companies compete for hospital share.

Direct peers

• Profarma Specialty: One of the largest pharmaceutical distributors in Brazil, serving pharmacies, hospitals, and clinics. Direct competitor to Stock Med in the institutional distribution channel.
• Panpharma: Brazilian pharmaceutical and medical-hospital supplies distributor serving healthcare institutions across multiple states. Closest comparable to Stock Med in business model, customer base, and product mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/stockmed.com.br
• LinkedInlinkedin.com/company/stock-med-produtos-medico-hospitalares
• Instagraminstagram.com/stock_med

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stock Med